• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类恶性与良性胰岛素瘤组织之间的生化差异。

Biochemical differences between human malignant and benign insulinoma tissues.

作者信息

Nakazawa I, Ohneda A, Mura K

出版信息

Tohoku J Exp Med. 1977 Mar;121(3):275-80. doi: 10.1620/tjem.121.275.

DOI:10.1620/tjem.121.275
PMID:193215
Abstract

Five cases of malignant insulinoma and 2 cases of benign insulinoma were studied lipid-chemically. Tissues were collected by surgical operation or biopsy under peritoneoscopy. The total lipid was extracted from each tissue, and one part of each total lipid was separated into phospholipid, triglyceride and other lipid fractions by a thin-layer chromatography (TLC) on silica gel. The fatty acid composition and fatty acid content of each lipid fraction were measured by a gas-liquid chromatography (GLC). The most remarkable difference between malignant and benign isulinoma tissues was a higher percentage value of eicosatrienoic acid in the phospholipid of malignant insulinoma tissues when compared with that of non-malignant insulinoma tissues; the values mentioned above distributed between 9.82 and 3.32 in 5 malignant cases, but were 2.89 and 2.57 in 2 benign cases. Those changes in the phospholipid fatty acid composition of malignant insulinoma tissues may represent one of the mechanisms of malignant growth in the malignant neoplastic tissue.

摘要

对5例恶性胰岛素瘤和2例良性胰岛素瘤进行了脂质化学研究。组织通过手术切除或腹腔镜活检采集。从每个组织中提取总脂质,然后将每个总脂质的一部分通过硅胶薄层层析(TLC)分离为磷脂、甘油三酯和其他脂质组分。通过气液色谱(GLC)测量每个脂质组分的脂肪酸组成和脂肪酸含量。恶性和良性胰岛素瘤组织之间最显著的差异是,与非恶性胰岛素瘤组织相比,恶性胰岛素瘤组织磷脂中二十碳三烯酸的百分比值更高;上述值在5例恶性病例中分布于9.82至3.32之间,但在2例良性病例中分别为2.89和2.57。恶性胰岛素瘤组织磷脂脂肪酸组成的这些变化可能代表了恶性肿瘤组织恶性生长的机制之一。

相似文献

1
Biochemical differences between human malignant and benign insulinoma tissues.人类恶性与良性胰岛素瘤组织之间的生化差异。
Tohoku J Exp Med. 1977 Mar;121(3):275-80. doi: 10.1620/tjem.121.275.
2
The lipid-chemical features of the metastatic tissues into the liver from the human gastric cancer, large intestinal cancer and malignant insulinoma.源自人类胃癌、大肠癌及恶性胰岛素瘤的肝脏转移组织的脂质化学特征。
Tohoku J Exp Med. 1978 Sep;126(1):95-101. doi: 10.1620/tjem.126.95.
3
High plasma pancreastatinlike immunoreactivity in a patient with malignant insulinoma.一名恶性胰岛素瘤患者血浆中胰抑制素样免疫反应性升高。
Gastroenterology. 1989 Nov;97(5):1313-8. doi: 10.1016/0016-5085(89)91705-8.
4
Lipid-chemical features of human gastric cancerous, polypous and ulcerative tissues.人胃癌、胃息肉和胃溃疡组织的脂质化学特征。
Tohoku J Exp Med. 1977 Dec;123(4):365-70. doi: 10.1620/tjem.123.365.
5
Further studies on lipid-chemical differences between cancerous and adenomatous polypous tissues in the human large intestine.关于人类大肠中癌组织与腺瘤性息肉组织脂质化学差异的进一步研究。
Tohoku J Exp Med. 1976;118 Suppl:117-25. doi: 10.1620/tjem.118.suppl_117.
6
The lipid-chemical features of the biopsied human liver tissues of patients with malignant neoplastic diseases.恶性肿瘤疾病患者活检的人体肝脏组织的脂质化学特征。
Tohoku J Exp Med. 1976;118 Suppl:149-58. doi: 10.1620/tjem.118.suppl_149.
7
C-peptide, insulin and proinsulinlike components in diabetic and nondiabetic human pancreas.糖尿病和非糖尿病患者胰腺中的C肽、胰岛素及胰岛素原样成分
Endocrinol Jpn. 1979 Jun;26(3):313-8. doi: 10.1507/endocrj1954.26.313.
8
Localization of proinsulin and insulin in human insulinoma: preliminary immunohistochemical results.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;56(5):287-92. doi: 10.1007/BF02890028.
9
The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations.胰岛素瘤患者的内分泌胰腺。对非肿瘤组织进行免疫细胞化学和超微结构研究并进行形态计量学评估。
Int J Pancreatol. 1989 Jul;5(1):11-28.
10
The extraction and purification of a peptide from rat insulinoma tissue.
Biochim Biophys Acta. 1989 Dec 8;993(2-3):275-9. doi: 10.1016/0304-4165(89)90176-1.